SwePub
Sök i LIBRIS databas

  Extended search

WFRF:(Denkert C.)
 

Search: WFRF:(Denkert C.) > ESMO Expert Consens...

  • Loibl, S.Goethe University (author)

ESMO Expert Consensus Statements on the management of breast cancer during pregnancy (PrBC)

  • Article/chapterEnglish2023

Publisher, publication year, extent ...

  • 2023
  • 18 s.

Numbers

  • LIBRIS-ID:oai:lup.lub.lu.se:37c13d00-8dfb-49b1-b0fe-44d0bc1af714
  • https://lup.lub.lu.se/record/37c13d00-8dfb-49b1-b0fe-44d0bc1af714URI
  • https://doi.org/10.1016/j.annonc.2023.08.001DOI
  • http://kipublications.ki.se/Default.aspx?queryparsed=id:154037991URI

Supplementary language notes

  • Language:English
  • Summary in:English

Part of subdatabase

Classification

  • Subject category:art swepub-publicationtype
  • Subject category:ref swepub-contenttype

Notes

  • The management of breast cancer during pregnancy (PrBC) is a relatively rare indication and an area where no or little evidence is available since randomized controlled trials cannot be conducted. In general, advances related to breast cancer (BC) treatment outside pregnancy cannot always be translated to PrBC, because both the interests of the mother and of the unborn should be considered. Evidence remains limited and/or conflicting in some specific areas where the optimal approach remains controversial. In 2022, the European Society for Medical Oncology (ESMO) held a virtual consensus-building process on this topic to gain insights from a multidisciplinary group of experts and develop statements on controversial topics that cannot be adequately addressed in the current evidence-based ESMO Clinical Practice Guideline. The aim of this consensus-building process was to discuss controversial issues relating to the management of patients with PrBC. The virtual meeting included a multidisciplinary panel of 24 leading experts from 13 countries and was chaired by S. Loibl and F. Amant. All experts were allocated to one of four different working groups. Each working group covered a specific subject area with two chairs appointed: 1. PrBC: incidence, epidemiology, biology and pathology, diagnostic work-up, staging and risk assessment, prognosis (Chairs: Vincent Vandecaveye, Fedro Peccatori). 2. Clinical pharmacology of systemic agents during pregnancy: management of localized disease and (neo) adjuvant therapies, management of systemic disease (Chairs: Giuseppe Curigliano, Peter Schmid). 3. Obstetric care and fetal/newborn follow-up and outcomes: metastases to fetus, management of pregnancy during anticancer therapy, lactation, psychological support (Chairs: Elyce Cardonick, Mathilde van Gerwen). Planning, preparation and execution of the consensus process was conducted according to the ESMO standard operating procedures.

Subject headings and genre

Added entries (persons, corporate bodies, meetings, titles ...)

  • Azim, H. A. (author)
  • Bachelot, T.Centre Léon Bérard (author)
  • Berveiller, P.University of Paris-Saclay,CHI Poissy (author)
  • Bosch, A.Lund University,Lunds universitet,Bröstcancer-genetik,Sektion I,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,Molekylära behandlingsstrategier vid bröstcancer,Forskargrupper vid Lunds universitet,LUCC: Lunds universitets cancercentrum,Övriga starka forskningsmiljöer,Breastcancer-genetics,Section I,Department of Clinical Sciences, Lund,Faculty of Medicine,Molecular therapeutics in breast cancer,Lund University Research Groups,LUCC: Lund University Cancer Centre,Other Strong Research Environments,Skåne University Hospital(Swepub:lu)med-abp (author)
  • Cardonick, E. (author)
  • Denkert, C.Philipp University of Marburg (author)
  • Halaska, M. J.Charles University in Prague (author)
  • Hoeltzenbein, M.Charité - University Medicine Berlin (author)
  • Johansson, A. L.V.Karolinska Institutet,Karolinska Institute,Cancer Registry of Norway, Institute of Population-Based Cancer Research,University Hospitals Leuven (author)
  • Maggen, C.Universitair Ziekenhuis Brussel (author)
  • Markert, U. R.Universitätsklinikum Jena (author)
  • Peccatori, F.European Institute of Oncology (author)
  • Poortmans, P.University of Antwerp,Queen Mary University (author)
  • Saloustros, E.University Hospital of Larissa (author)
  • Saura, C.Vall d’Hebron Institute of Oncology (author)
  • Schmid, P.Queen Mary University (author)
  • Stamatakis, E.Alexandra Hospital, Athens (author)
  • van den Heuvel-Eibrink, M.Princess Maxima Center for Pediatric Oncology/Hematology (author)
  • van Gerwen, M.Princess Maxima Center for Pediatric Oncology/Hematology,University of Amsterdam,Antoni Van Leeuwenhoek Hospital (author)
  • Vandecaveye, V.University Hospitals Leuven (author)
  • Pentheroudakis, G. (author)
  • Curigliano, G.University of Milan,European Institute of Oncology (author)
  • Amant, F.Antoni Van Leeuwenhoek Hospital,University Hospitals Leuven (author)
  • Goethe UniversityCentre Léon Bérard (creator_code:org_t)

Related titles

  • In:Annals of Oncology34:10, s. 849-8660923-7534
  • In:Annals of oncology : official journal of the European Society for Medical Oncology34:10, s. 849-8661569-8041

Internet link

Find in a library

To the university's database

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view